IMA · ImageneBio, Inc. · Documents

$4.02 -0.07 (-1.71%) At close · Nov 3

Market Cap

$45.63M

11.35M

Volume · Nov 3 9065 Avg daily vol (3M) 13.65K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $800K down 77.1% 10-K filed Mar 10, 2026 Quarterly report FY2026 Q2 Net loss $10.18M 10-Q filed Aug 5, 2026 Latest results Financial results 8-K filed Aug 5, 2026

2026

Sep 14

Investor event

H.C. Wainwright 28th Annual Global Investment Conference AI summary on its way

Aug 5

Quarterly report 10-Q FY2026 Q2, ended Jun 30

Quarterly report for FY2026 Q2 AI summary on its way

Net loss $10.18M Diluted EPS -$0.63

Aug 5

Registration statement S-3

Registration statement AI summary on its way

Aug 5

Registration statement S-3

Registration statement AI summary on its way

Aug 5

Current report 8-K

Financial results AI summary on its way

Jul 23

Current report 8-K Events of Jul 20

Director or officer change, or executive pay, Other events AI summary on its way

Jun 26

Current report 8-K Events of Jun 22

Director or officer change, or executive pay AI summary on its way

Jun 17

Current report 8-K Events of Jun 16

Director or officer change, or executive pay, Shareholder vote results AI summary on its way

Jun 4

Investor event

Jefferies Global Healthcare Conference AI summary on its way

May 7

Current report 8-K

Financial results AI summary on its way

May 7

Quarterly report 10-Q FY2026 Q1, ended Mar 31

Quarterly report for FY2026 Q1 AI summary on its way

Net loss $10.62M Diluted EPS -$0.95

Apr 30

Proxy statement DEF 14A Meeting Jun 16, 2026

Proxy statement AI summary on its way

Apr 30

Annual report to holders ARS

Annual report to holders AI summary on its way

Apr 30

Proxy statement DEFA14A

Proxy statement AI summary on its way

Apr 13

Current report 8-K Events of Apr 12

Entered into a material agreement, Unregistered sale of equity AI summary on its way

Mar 17

Current report 8-K Events of Mar 12

Director or officer change, or executive pay AI summary on its way

Mar 10

Current report 8-K

Financial results AI summary on its way

Mar 10

Annual report 10-K FY2025, ended Dec 31

Annual report for FY2025 AI summary on its way

Revenue $800K ▼ 77.1% Net loss $45.35M Diluted EPS -$9.64

Feb 17

Current report 8-K Events of Feb 12

Director or officer change, or executive pay AI summary on its way

2025

Dec 18

Current report 8-K Events of Dec 12

Director or officer change, or executive pay

Nov 19

Current report 8-K

Regulation FD disclosure

Nov 12

Current report 8-K

Financial results

Nov 12

Quarterly report 10-Q FY2025 Q3, ended Sep 30

Quarterly report for FY2025 Q3

Revenue $0 Net loss $24.78M Diluted EPS -$2.91

Nov 5

Current report 8-K Events of Nov 1

Director or officer change, or executive pay

Oct 29

Current report 8-K Events of Oct 23

Entered into a material agreement, Ended a material agreement

Oct 22

Current report 8-K Events of Oct 21

Director or officer change, or executive pay

Oct 10

Current report 8-K

Director or officer change, or executive pay

Sep 8

Registration statement S-1

Registration statement

Aug 12

Current report 8-K/A Events of Jul 25

Completed an acquisition or sale of assets

Aug 5

Current report 8-K Events of Aug 2

Change of auditor

Aug 1

Current report 8-K Events of Jul 28

Director or officer change, or executive pay, Other events

Jul 29

Current report 8-K Events of Jul 25

Entered into a material agreement, Completed an acquisition or sale of assets, Unregistered sale of equity, Change to shareholders' rights, Change in control, Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Change in shell company status, Regulation FD disclosure

Jul 25

Current report 8-K

Regulation FD disclosure

Jul 24

Current report 8-K

Other events

Jul 24

Quarterly report 10-Q FY2025 Q2, ended Jun 30

Quarterly report for FY2025 Q2

Net loss $2.77M Diluted EPS -$0.06

Jul 22

Current report 8-K

Other events

Jul 16

Current report 8-K Events of Jul 15

Director or officer change, or executive pay

Jul 15

Current report 8-K

Director or officer change, or executive pay, Shareholder vote results, Other events

Jul 11

Current report 8-K

Other events

Jul 1

Current report 8-K

Regulation FD disclosure, Other events

Jun 9

Registration statement S-4/A

Registration statement

May 30

Registration statement S-4/A

Registration statement

May 20

Registration statement S-4/A

Registration statement

May 8

Quarterly report 10-Q FY2025 Q1, ended Mar 31

Quarterly report for FY2025 Q1

Net loss $8.62M Diluted EPS -$0.18

May 7

Registration statement S-4/A

Registration statement

Apr 21

Registration statement S-4/A

Registration statement

Mar 18

Registration statement S-4

Registration statement

Mar 6

Annual report 10-K FY2024, ended Dec 31

Annual report for FY2024

Net loss $49.23M Diluted EPS -$1.02

Mar 6

Annual report to holders ARS

Annual report to holders

2024

Dec 23

Current report 8-K

Entered into a material agreement, Unregistered sale of equity, Change in control, Director or officer change, or executive pay, Regulation FD disclosure

Showing 1–50 of 105 documents

Key facts CIK 1835579 CUSIP 45175G207 13F (30d) 1 filings 1 filers Visit website Investor relations